Skip to main content
Livermore
Livermore
ZHEN

Amara Financial, LLC.

SEC CIK
0001934965
Latest filing
Aug 7, 2026

The latest 13F from Amara Financial, LLC. covers Q2 2026 (filed Aug 7, 2026): 48 long positions worth $167.1M. The top 10 holdings make up 79.0% of the portfolio, and the largest is Vanguard World FD at 16.6%. Livermore has 8 filings on Form 13F from this institution, going back to Q3 2024.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
3
Est. +$685.6K
Added
28
Est. +$5.03M
Reduced
12
Est. −$857.0K
Sold out
0

Top 5 holdings

Share of this quarter's portfolio value

  1. Vanguard World FD921910816
    16.6%$27.8M
  2. Vanguard Ftse Developed Markets ETF921943858
    16.4%$27.3M
  3. Vanguard Dividend Appreciation ETF921908844
    13.7%$22.8M
  4. Vanguard World FD921910840
    7.8%$13.0M
  5. Schwab U.S. Large-Cap Growth ETF808524300
    6.4%$10.7M

Biggest buys

New and added positions, by estimated amount bought

  1. Vanguard Ftse Developed Markets ETF921943858
    +$1.63MAdded
  2. Vanguard World FD921910840
    +$1.11MAdded
  3. iShares Core S&P Small Cap ETF464287804
    +$330.1KAdded
  4. Vanguard Dividend Appreciation ETF921908844
    +$329.1KAdded
  5. iShares Tr46429B747
    +$271.6KAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. Vanguard World FD921910816
    +0.77 pp15.9% → 16.6%
  2. Vanguard World FD921910840
    +0.51 pp7.2% → 7.8%
  3. Vanguard Ftse Developed Markets ETF921943858
    +0.42 pp15.9% → 16.4%
  4. iShares Core S&P Small Cap ETF464287804
    +0.31 pp3.1% → 3.4%
  5. iShares Core MSCI Emerging Markets ETF46434G103
    +0.19 pp2.7% → 2.9%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CVSCVS Health Corp
    −$345.2KReducedHistory
  2. iShares Core S&P Mid-Cap ETF464287507
    −$177.2KReduced
  3. PIMCO ETF Tr72201R643
    −$153.6KReduced
  4. Vanguard Morningstar Growth ETF922908736
    −$57.0KReducedConverted for a 6-for-1 split
  5. Vanguard Morningstar Value ETF922908744
    −$45.8KReduced

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. GLDSPDR Gold Trust
    −0.25 pp0.9% → 0.7%History
  2. GLTRabrdn Precious Metals Basket ETF Trust
    −0.21 pp0.7% → 0.5%History
  3. PIMCO ETF Tr72201R643
    −0.15 pp0.4% → 0.3%
  4. CVSCVS Health Corp
    −0.14 pp0.3% → 0.1%History
  5. Vanguard Morningstar Value ETF922908744
    −0.13 pp3.0% → 2.8%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$167.1M
+$22.0M (+15.2%) vs. prior quarter
Positions
48
+3 vs. prior quarter
Top 10 concentration
79.0%
Top 10 as share of value
Turnover
0.5%
Q2 2026, one quarter
Average holding period
7.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q3 2024), so positions held before then are understated.

13F filings by quarter

8 quarters, going back to Q3 2024. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $167.1M (Q2 2026)

Q3 2024: $104.5MQ4 2024: $108.4MQ1 2025: $108.2MQ2 2025: $113.5MQ3 2025: $135.8MQ4 2025: $144.4MQ1 2026: $145.1MQ2 2026: $167.1M
Q3 2024Q2 2026
13F filings of Amara Financial, LLC. by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 7, 202648$167.1MVanguard World FDVanguard Ftse Developed Markets ETFVanguard Dividend Appreciation ETFvs. Q1 2026SEC
Q1 2026May 7, 202645$145.1MVanguard Ftse Developed Markets ETFVanguard World FDVanguard Dividend Appreciation ETFvs. Q4 2025SEC
Q4 2025Feb 3, 202646$144.4MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETFvs. Q3 2025SEC
Q3 2025Nov 10, 202547$135.8MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETFvs. Q2 2025SEC
Q2 2025Aug 11, 202543$113.5MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETFvs. Q1 2025SEC
Q1 2025Apr 25, 202545$108.2MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETFvs. Q4 2024SEC
Q4 2024Feb 6, 202547$108.4MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETFvs. Q3 2024SEC
Q3 2024Nov 7, 202442$104.5MVanguard World FDVanguard Dividend Appreciation ETFVanguard Ftse Developed Markets ETF–SEC